An Israeli-based BioPass Pharma Ltd. is developing a revolutionary formulation intended for the treatment of CNS diseases. Utilizing its patented novel formulation of intranasal administration. This technology is designed to deliver drugs directly into the brain by bypassing the BBB.
Our novel nasal formulation offers short onset of a non-invasive, painless, easily administered treatment, avoiding gastrointestinal and hepatic presystemic metabolism.
Company Details
- Employees
- 1
- Founded
- 2021
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Biopass Pharma Questions
Biopass Pharma's LinkedIn profile is https://www.linkedin.com/company/biopass-pharma
Biopass Pharma has
1 employees.
View email and phone details for 1
employees at Biopass Pharma.
Biopass Pharma's industry is
Biotechnology Research
Biopass Pharma's top competitors are
Tq (Tecnoquímicas),
Go-Out,
Biopass,
Laboratorios Biopas,
Swixx Biopharma,
Astrazeneca,
Johnson & Johnson,
Roche Colombia,
Biopass Id,
Procaps.
Biopass Pharma's categories are Biotechnology Research
Biopass Pharma's founding year is 2021
